Join TC and Georgia for Gabriel Grego’s return visit to The Chartcast where he discusses the accusations he’s made against Penumbra (NYSE: PEN) for releasing a fatally flawed medical device into the market, the company’s response, and what is next in his crusade against the company’s management team.
[Promo Tweet] | Check out Episode #30, our first interview with Gabriel!
Folks, given where we are in the cycle, the work being done by @TESLAcharts and @georgia_orwell_ in chronicling fraud I s getting more important by the day.
We are in the golden age of fraud and you’re gonna want to hear these stories. They may save your money and your sanity https://t.co/Mn0pwGt2iG
— Grant Williams (@ttmygh) December 20, 2020
Transcript
(Coming soon!)